Back to results
US 2026/0308109 A1Published application
Conformationally restricted phenethylamine analogs
OwnerDavid E. Nicholsinventor
Life of this patent
Estimating the term…
Abstract
The present disclosure relates in some aspects to certain phenethylamine analogs, such as benzocyclobutene and benzocyclopentene analogs, including those of Formula (1). Also provided are methods of synthesizing the compounds, compositions containing the compounds, and methods of using the compounds and compositions. In some aspects, the compounds are useful as therapeutic agents, for example as neuromodulatory agents and as anti-inflammatory agents.
Claims27
A compound of Formula (1):
- or a pharmaceutically acceptable salt, stereoisomer, hydrate, solvate, or isotopic derivative thereof, wherein:
- R1 is H or —OCH3;
- R2 is H, or is taken together with R3 to form a methylenedioxy group;
- R3 is H, Br, Cl, I, C1-C6 alkyl, C1-C6 alkylthio, or C3-C6 cycloalkylmethyl;
- or R3 is taken together with R2 to form a methylenedioxy group;
- R4 is H, —OCH3, or —CH2CH2OCH3;
- R′ is H or C1-C6 alkyl;
- and
- n is 1 or 2;
- and
- when R3 is H or Br, R4 is not —OCH3;
- and
- when R2 and R3 are taken together to form a methylenedioxy group, and R1 and R4 are both H, R′ is C1-C6 alkyl.
10 more elements
8-9. (canceled)
(canceled)
(canceled)
20-30. (canceled)
33-38. (canceled)
41-49. (canceled)
51-112. (canceled)
Dependencies are inferred from the claim text.